SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-031228
Filing Date
2019-05-22
Accepted
2019-05-22 21:43:43
Documents
2
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 7489
2 EX-24 ex-24.htm EX-24 10341
  Complete submission text file 0001104659-19-031228.txt   19949
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38916 | Film No.: 19847803
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Reporting) CIK: 0001297709 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38916 | Film No.: 19847802

Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS Ltd (Issuer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations